Showing results (21-30 of 893) with videos related to
Sort By:
Pageof 90
Clinical Calcium|April 4, 2007
[RANKL as a target molecule for treatment of joint destruction]Sakae TanakaAmerican Journal of Nephrology|July 27, 2007
Signaling axis in osteoclast biology and therapeutic targeting in the RANKL/RANK/OPG systemSakae TanakaAnnals of the New York Academy of Sciences|April 16, 2010
Antiapoptotic molecule Bcl-2 is essential for the anabolic activity of parathyroid hormone in boneYuichi Nagase, Mitsuyasu Iwasawa, Toru Akiyama, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 19, 2012
Class IA phosphatidylinositol 3-kinase regulates osteoclastic bone resorption through protein kinase B-mediated vesicle transportMasahiro Shinohara, Masaki Nakamura, Hironari Masuda, et al.Clinical Calcium|September 5, 2006
[Current topics in drug therapy aiming at bone resorption]Tetsuro Yasui, Sakae TanakaClinical Calcium|March 26, 2016
[Transcriptome analysis and epigenetic analysis during osteoclastogenesis]Shinya Nakamura, Sakae TanakaCurrent Opinion in Cell Biology|February 10, 2022
Plasmalemmal interface for calcium signaling in osteoclast differentiationHiroyuki Okada, Sakae TanakaClinical Calcium|March 3, 2009
[Prevention of joint destruction by osteoclast-targeting therapy in search of new tools, such as OPG or cathepsin K inhibitor]Yuho Kadono, Sakae TanakaNihon Rinsho. Japanese Journal of Clinical Medicine|September 17, 2005
[RANKL vaccination]Takuo Juji, Sakae TanakaPageof 90